176 related articles for article (PubMed ID: 22262497)
1. Productivity costs and medical costs among working patients with knee osteoarthritis.
Hermans J; Koopmanschap MA; Bierma-Zeinstra SM; van Linge JH; Verhaar JA; Reijman M; Burdorf A
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):853-61. PubMed ID: 22262497
[TBL] [Abstract][Full Text] [Related]
2. Cost analysis of intra-articular sodium hyaluronate treatment in knee osteoarthritis patients who failed conservative treatment.
Turajane T; Labpiboonpong V; Maungsiri S
J Med Assoc Thai; 2007 Sep; 90(9):1839-44. PubMed ID: 17957928
[TBL] [Abstract][Full Text] [Related]
3. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intra-articular hyaluronic acid injections and mud-pack therapy in the treatment of knee osteoarthritis.
Bostan B; Sen U; Güneş T; Sahin SA; Sen C; Erdem M; Erkorkmaz U
Acta Orthop Traumatol Turc; 2010; 44(1):42-7. PubMed ID: 20513990
[TBL] [Abstract][Full Text] [Related]
5. Cost-Utility Analysis of High Molecular Weight Hyaluronic Acid for Knee Osteoarthritis in Everyday Clinical Care in Patients at a Working Age: An Economic Evaluation of a Randomized Clinical Trial.
Hermans J; Reijman M; Goossens LMA; Verburg H; Bierma-Zeinstra SMA; Koopmanschap MA
Arthritis Care Res (Hoboken); 2018 Jan; 70(1):89-97. PubMed ID: 28320075
[TBL] [Abstract][Full Text] [Related]
6. [Study on the effect of sodium hyaluronate intra-articular injection on the treatment of knee osteoarthritis].
Xu P; Zhang Y; Yao J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):210-4. PubMed ID: 15828478
[TBL] [Abstract][Full Text] [Related]
7. Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis.
Theiler R; Brühlmann P
Curr Med Res Opin; 2005 Nov; 21(11):1727-33. PubMed ID: 16307692
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect costs attributable to osteoarthritis in active subjects.
Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of intra-articular injection of sodium hyaluronate for the treatment of osteoarthritis of the knee.
Turajane T; Tanavaree A; Labpiboonpong V; Maungsiri S
J Med Assoc Thai; 2007 Sep; 90(9):1845-52. PubMed ID: 17957929
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of knee and hip osteoarthritis in Spain.
Loza E; Lopez-Gomez JM; Abasolo L; Maese J; Carmona L; Batlle-Gualda E;
Arthritis Rheum; 2009 Feb; 61(2):158-65. PubMed ID: 19177521
[TBL] [Abstract][Full Text] [Related]
11. Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis.
Dagenais S
Issues Emerg Health Technol; 2006 Nov; (94):1-4. PubMed ID: 17096501
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
[TBL] [Abstract][Full Text] [Related]
13. Joint-pain comorbidity, health status, and medication use in hip and knee osteoarthritis: a cross-sectional study.
Hoogeboom TJ; den Broeder AA; Swierstra BA; de Bie RA; van den Ende CH
Arthritis Care Res (Hoboken); 2012 Jan; 64(1):54-8. PubMed ID: 21954220
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F; Gebhardt U; Meng T; Murray C
Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
[TBL] [Abstract][Full Text] [Related]
16. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study.
Goorman SD; Watanabe TK; Miller EH; Perry C
Arch Phys Med Rehabil; 2000 Apr; 81(4):479-83. PubMed ID: 10768539
[TBL] [Abstract][Full Text] [Related]
17. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
Bagga H; Burkhardt D; Sambrook P; March L
J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition.
Gupta S; Hawker GA; Laporte A; Croxford R; Coyte PC
Rheumatology (Oxford); 2005 Dec; 44(12):1531-7. PubMed ID: 16091394
[TBL] [Abstract][Full Text] [Related]
19. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
20. Relative costs and effectiveness of specialist and general internist ambulatory care for patients with 2 chronic musculoskeletal conditions.
Anderson JJ; Ruwe M; Miller DR; Kazis L; Felson DT; Prashker M
J Rheumatol; 2002 Jul; 29(7):1488-95. PubMed ID: 12136910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
